Capsaicin nose spray for acute stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a capsaicin spray applied inside the nose to stimulate a nerve cluster behind the nose, which may help improve blood flow in people having a moderate to severe stroke within the last 24 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 80 years old.
- You must be having a moderate or severe stroke, with certain neurological symptoms.
- Your stroke symptoms must have started within the last 24 hours.
- You must have been mostly independent before the stroke, able to do daily activities without help.
- You must agree to participate or have someone legally authorized to consent for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a nasal spray containing tiny particles from donated stem cells can help people recover from a recent ischemic stroke. The treatment is given as a nose spray, and you will be monitored for up to 14 days after your stroke.
This trial tests whether an investigational study drug can improve outcomes after an acute ischemic stroke (a stroke caused by blocked blood flow). You may be eligible if you are able to start treatment quickly after symptom onset and have a moderate stroke severity on a standard stroke exam.
This trial tests whether lowering body temperature (targeted temperature management) can help people who have had a stroke within the last 48 hours. It focuses on strokes caused by a blockage in a specific part of the brain's blood supply, and aims to see if cooling can reduce brain damage.
This trial tests whether giving acetaminophen (a common pain and fever medicine) can improve recovery after a stroke caused by a blocked large artery. It is for patients who have already had a procedure to open that artery. The goal is to see if the medicine can protect the brain and lead to better outcomes.
This trial tests whether combining local cooling with a procedure to reopen blocked arteries can help people who have had a severe stroke with a large area of brain damage. It looks at patients who can be treated within 24 hours of symptoms starting.
This trial tests whether adding carbon dioxide (CO2) to the standard medicine phenylephrine is better than phenylephrine alone for people whose stroke symptoms are getting worse. The goal is to see if the combination treatment helps improve blood flow to the brain.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.